Nabota 100unit: Understanding Its Global Regulatory and Market Access Status
For professionals considering the procurement of Nabota 100unit, understanding its global market access and regulatory standing is essential for compliant sourcing and practice. This article provides

For professionals considering the procurement of Nabota 100unit, understanding its global market access and regulatory standing is essential for compliant sourcing and practice. This article provides an overview of Nabota 100unit's key certifications and market presence, detailing the requirements and considerations for clinics and distributors operating internationally.
Nabota 100unit: Product Profile for Professionals
Nabota 100unit is a botulinum toxin type A product manufactured by Daewoong, a South Korean pharmaceutical company. It is presented in a 100-unit vial, primarily intended for aesthetic applications by qualified medical professionals. This product is a key offering in the neurotoxin category for clinics and distributors. For a broader selection, explore our Botulinum toxin / neurotoxin catalog, which includes other options such as Nabota 200unit.
Core Regulatory Approvals and Certifications
Understanding the foundational regulatory approvals for Nabota 100unit is crucial for compliant sourcing:
- KFDA Approval: As a product originating from South Korea, Nabota 100unit is fully approved by the Korean Ministry of Food and Drug Safety (KFDA). This certification is fundamental for its production and domestic distribution.
- FDA Approval (USA): An equivalent formulation of Nabota is approved by the US Food and Drug Administration (FDA) for the temporary improvement in the appearance of moderate to severe glabellar lines. It is marketed in the United States under the brand name Jeuveau by Evolus, Inc.
- CE Mark (Europe): [VERIFY: Specific CE Mark status for Nabota 100unit for direct aesthetic use in the EU/UK.] Professionals should verify the CE marking directly on product packaging or via supplier documentation for products intended for the European Union or United Kingdom markets.
- GMP & ISO Standards: Daewoong's manufacturing processes adhere to stringent Good Manufacturing Practices (GMP) and relevant ISO certifications, ensuring high-quality pharmaceutical production standards.
Navigating Global Market Access
Market access for Nabota 100unit varies significantly across different regions:
- North America (USA): Available via Evolus, Inc. as Jeuveau.
- South Korea: Fully approved and widely available in its home market.
- Europe & UK: Market access may occur through specific distributors under different brand names, or require careful consideration of parallel import regulations. Clinics must verify local authorization for any specific product version.
- GCC Region: Regulatory approval processes are unique to each country (e.g., SFDA in Saudi Arabia, MOH in UAE). Sourcing requires confirmation of local product registration from the supplier.
- LATAM: Market access varies by country, requiring national regulatory body approval (e.g., ANVISA in Brazil, INVIMA in Colombia, COFEPRIS in Mexico).
- APAC (excluding S. Korea): Nabota is present in various markets such as Thailand, the Philippines, and Vietnam, subject to their respective national health authority approvals.
Parallel Import and Compliant Sourcing Practices
Parallel import refers to the process of purchasing a legitimate, market-approved product from one country and importing it into another without the original manufacturer's direct distribution authorization for that specific batch to that specific country. For professionals, understanding these regulations is critical. While a product like Nabota 100unit is globally recognized as authentic, its legal status for import and use can differ based on local laws and the specific origin of the batch. Always ensure your supplier provides documentation confirming the product's legal journey and compliance with your local regulatory framework. Similar sourcing vigilance applies when stocking products like Re N Tox 100unit.
Essential Documentation for Professional Procurement
When procuring Nabota 100unit, clinics and distributors should demand comprehensive documentation to ensure authenticity and compliance:
- Certificate of Authenticity (COA): Verifies the product's origin and genuine nature.
- Lot Number Traceability: Allows tracking of the specific product batch from its manufacturing point to your clinic.
- Cold Chain Compliance: Documentation confirming continuous temperature control during transit is critical for maintaining the integrity of botulinum toxins.
- Manufacturer Batch Certificates: May be requested for specific quality assurance checks.
- Customs Declarations: Proof of legal import where applicable.
For further insights on verifying product authenticity, refer to guides like our article on Verifying Genuine Monalisa Touch.
Sourcing genuine Nabota 100unit is paramount for professional integrity and patient safety. We prioritize providing original products with verified traceability, offering transparent lot numbers and certificates of authenticity. Our logistics adhere to strict cold chain protocols, ensuring product integrity from our facilities to your clinic. Demand these assurances from your supplier to uphold the highest standards in your aesthetic practice.
For professional buyers.
What is the primary regulatory approval for Nabota 100unit?+
Is Nabota 100unit approved for use in the European Union or the UK?+
How can I verify the authenticity of Nabota 100unit?+
Does Nabota 100unit meet Good Manufacturing Practices (GMP) standards?+
What are the general considerations for parallel importing Nabota 100unit?+
Can I source Nabota 100unit for my clinic in Latin America or the GCC?+
Explore our full selection of aesthetic injectables and secure Nabota 100unit with verified traceability. Contact our wholesale team via WhatsApp or browse our product catalog for professional pricing.
Authentic, lot-traceable and cold-chain shipped to verified clinics. Volume pricing unlocks automatically — save up to 8% on orders of 51+ units.


